Source: JACC: Cardiovascular Imaging. Unidade: HU
Subjects: DOENÇAS CARDIOVASCULARES, VASOS CORONÁRIOS, CÁLCIO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
ABNT
CAINZOS-ACHIRICA, Miguel et al. Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention. JACC: Cardiovascular Imaging, v. 14, n. 5, p. 1005-1016, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jcmg.2020.10.016. Acesso em: 06 out. 2024.APA
Cainzos-Achirica, M., Bittencourt, M. S., Osei, A. D., Haque, W., Bhatt, D. L., Blumenthal, R. S., et al. (2021). Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention. JACC: Cardiovascular Imaging, 14( 5), 1005-1016. doi:10.1016/j.jcmg.2020.10.016NLM
Cainzos-Achirica M, Bittencourt MS, Osei AD, Haque W, Bhatt DL, Blumenthal RS, Blankstein R, Ray KK, Blaha MJ, Nasir K. Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention [Internet]. JACC: Cardiovascular Imaging. 2021 ; 14( 5): 1005-1016.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.jcmg.2020.10.016Vancouver
Cainzos-Achirica M, Bittencourt MS, Osei AD, Haque W, Bhatt DL, Blumenthal RS, Blankstein R, Ray KK, Blaha MJ, Nasir K. Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention [Internet]. JACC: Cardiovascular Imaging. 2021 ; 14( 5): 1005-1016.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.jcmg.2020.10.016